Skip to content
Open access

Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study.

Sep 2026 · International Journal of Cardiology · Vol 464, pp. 134934 · 1 citation · 32 references
Medicine

TL;DR

In this selected cohort of adults at increased CV risk, persistent CRP elevation was associated with higher risk of incident HF and all-cause mortality and may suggest the prognostic relevance of elevated CRP and warrant further study of inflammation in HF development.

Abstract

Background

Systemic inflammation has been associated with heart failure (HF) development. C-reactive protein (CRP) is a sensitive marker of inflammation, but its prognostic association with incident HF remains incompletely defined. We explored whether persistent CRP elevation was associated with incident HF among adults at increased cardiovascular (CV) risk.

Methods

We identified 64,743 adults aged 40-80 years from the TriNetX Global Research Network with available body mass index, at least two cardiovascular risk factors, and at least two consecutive CRP measurements within the same predefined range. Participants were categorized as having low (0.1-3.0 mg/L) or elevated CRP (3.1-10.0 mg/L). The primary outcome was incident HF over a maximum follow-up of 10 years. Propensity-score matching was used to balance key baseline characteristics (including CV risk factors).

Results

After matching, each group included 19,547 participants. Elevated CRP was associated with higher risks of incident HF (overall: HR 1.34 [95% CI 1.22-1.48]), all-cause mortality (HR 1.90 [95% CI, 1.67-2.17]), and their composite (HR 1.49 [95% CI 1.37-1.62]). In exploratory phenotype-specific analyses, directionally consistent associations were observed for code-defined HFrEF (HR, 1.53; 95% CI, 1.30-1.80) and HFpEF (HR, 1.44; 95% CI, 1.24-1.66). Exploratory subgroup analyses suggested a stronger association among participants without obesity (P for heterogeneity =0.004).

Conclusions

In this selected cohort of adults at increased CV risk, persistent CRP elevation was associated with higher risk of incident HF and all-cause mortality. These findings may suggest the prognostic relevance of elevated CRP and warrant further study of inflammation in HF development.

Read PDF

Similar papers

Open access Oct 2026

High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study.

BACKGROUND AND HYPOTHESIS The burden and prognostic significance of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior studies yielding conflicting estimates of the association between elevated high-sensitivity C-reactive protein (hsCRP) and cardio-kidney outcomes. METHODS Observati...

F. Mazhar, Minjung Han, Katherine R. Tuttle et al. · 0 citations
Open access Oct 2026

Prognostic impact of high-sensitivity C-reactive protein trajectories and sustained residual inflammation for prediction of cardiovascular outcomes

Traditional risk factors for atherosclerotic cardiovascular disease (ASCVD) fail to fully reflect the residual risk, driven by chronic low-grade inflammation, observed in many. Generally, high-sensitivity C-reactive protein (hsCRP) concentrations remain stable, but some individuals may experience increases. More...

F. Kahles, M. Reugels, K. Schneider et al. · 0 citations
Open access Oct 2026

High-sensitivity C-reactive protein and all-cause mortality in patients with ischemic heart failure with reduced ejection fraction

Systemic inflammation contributes to the development and progression of ischemic heart failure with reduced ejection fraction (HFrEF). High-sensitivity C-reactive protein (hs-CRP) may help identify high-risk patients, but determinants of elevated hs-CRP and its prognostic value in ischemic HFrEF require further c...

A. Cai, W. Qiu, L. Li · 0 citations
Nov 2026

Abstract 8341: High-Sensitivity C-Reactive Protein, All-Cause Mortality and Heart Failure Hospitalization After Acute Coronary Syndrome in Type 2 Diabetes: Insights from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) Trial

Background: Patients with type 2 diabetes (T2D) remain at high risk for adverse outcomes after acute coronary syndrome (ACS). High-sensitivity C-reactive protein (hsCRP) may identify residual risk in this setting. Objective: To evaluate whether baseline hsCRP is associated with all-cause mortality (ACM) and he...

V. Anagnostopoulou, Guang K. Zhang, N. Girerd et al. · 0 citations
Open access Oct 2026

Longitudinal high-sensitivity C-reactive protein assessment predicts cardiovascular risk in apparently healthy individuals

High-sensitivity C-reactive protein (hsCRP) is the guideline-recommended biomarker for assessment of residual inflammatory risk in atherosclerotic cardiovascular disease (ASCVD). Clinical adoption remains limited, especially in individuals without established ASCVD. This study used longitudinal measurements to ev...

B. Kurt, M. Reugels, K. Schneider et al. · 0 citations
Open access Oct 2026

Trajectories of C-reactive protein levels after incident myocardial infarction and its association with risk of recurrent cardiovascular events in Danish patients – a registry-based cohort study

C-reactive protein (CRP) is a well-established marker of inflammation and is widely measured in the Danish hospital setting. Myocardial infarction (MI) causes an acute inflammatory response, including an increase in CRP, which is also an established risk factor for both incident and recurrent MI. Clinical trials...

M. M. Flege, S. Hansen, M. Winther-Jensen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.